Kiara Chu-Mei Chang1, Michael Soljak2, John Tayu Lee2, Maria Woringer2, Desmond Johnston3, Kamlesh Khunti4, Azeem Majeed2, Christopher Millett2. 1. Department of Primary Care and Public Health, Imperial College London, W6 8RP London, UK. Electronic address: chu-mei.chang@imperial.ac.uk. 2. Department of Primary Care and Public Health, Imperial College London, W6 8RP London, UK. 3. Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London W2 1PG, UK. 4. Diabetes Research Centre, Leicester Diabetes Centre, University of Leicester, Leicester LE5 4PW, UK.
Abstract
OBJECTIVE: To determine coverage of NHS Health Check, a national cardiovascular risk assessment programme in England, in the first four years after implementation, and to examine prevalence of high cardiovascular disease (CVD) risk and uptake of statins in high risk patients. METHOD: Study sample was 95,571 patients in England aged 40-74years continuously registered with 509 practices in the Clinical Practice Research Datalink between April 2009 and March 2013. Multilevel logistic regression models were used to assess predictors of Health Check attendance; elevated CVD risk factors and statin prescribing among attendees. RESULTS: Programme coverage was 21.4% over four years, with large variations between practices (0%-72.7%) and regions (9.4%-30.7%). Coverage was higher in older patients (adjusted odds ratio 2.88, 95% confidence interval 2.49-3.31 for patients 70-74years) and in patients with a family history of premature coronary heart disease (2.37, 2.22-2.53), but lower in Black Africans (0.75, 0.61-0.92) and Chinese (0.68, 0.47-0.96) compared with White British. Coverage was similar in patients living in deprived and affluent areas. Prevalence of high CVD risk (QRISK2≥20%) among attendees was 4.6%. One third (33.6%) of attendees at high risk were prescribed a statin after Health Checks. CONCLUSIONS: Coverage of the programme and statin prescribing in high risk individuals was low. Coverage was similar in deprived and affluent groups but lower in some ethnic minority groups, possibly widening inequalities. These findings raise a question about whether recommendations by WHO to develop CVD risk assessment programmes internationally will deliver anticipated health benefits.
OBJECTIVE: To determine coverage of NHS Health Check, a national cardiovascular risk assessment programme in England, in the first four years after implementation, and to examine prevalence of high cardiovascular disease (CVD) risk and uptake of statins in high risk patients. METHOD: Study sample was 95,571 patients in England aged 40-74years continuously registered with 509 practices in the Clinical Practice Research Datalink between April 2009 and March 2013. Multilevel logistic regression models were used to assess predictors of Health Check attendance; elevated CVD risk factors and statin prescribing among attendees. RESULTS: Programme coverage was 21.4% over four years, with large variations between practices (0%-72.7%) and regions (9.4%-30.7%). Coverage was higher in older patients (adjusted odds ratio 2.88, 95% confidence interval 2.49-3.31 for patients 70-74years) and in patients with a family history of premature coronary heart disease (2.37, 2.22-2.53), but lower in Black Africans (0.75, 0.61-0.92) and Chinese (0.68, 0.47-0.96) compared with White British. Coverage was similar in patients living in deprived and affluent areas. Prevalence of high CVD risk (QRISK2≥20%) among attendees was 4.6%. One third (33.6%) of attendees at high risk were prescribed a statin after Health Checks. CONCLUSIONS: Coverage of the programme and statin prescribing in high risk individuals was low. Coverage was similar in deprived and affluent groups but lower in some ethnic minority groups, possibly widening inequalities. These findings raise a question about whether recommendations by WHO to develop CVD risk assessment programmes internationally will deliver anticipated health benefits.
Authors: Adam Martin; Catherine L Saunders; Emma Harte; Simon J Griffin; Calum MacLure; Jonathan Mant; Catherine Meads; Fiona M Walter; Juliet A Usher-Smith Journal: Br J Gen Pract Date: 2018-06-18 Impact factor: 5.386
Authors: Chris Kypridemos; Kirk Allen; Graeme L Hickey; Maria Guzman-Castillo; Piotr Bandosz; Iain Buchan; Simon Capewell; Martin O'Flaherty Journal: BMJ Date: 2016-06-08
Authors: Edo Richard; Susan Jongstra; Hilkka Soininen; Carol Brayne; Eric P Moll van Charante; Yannick Meiller; Bram van der Groep; Cathrien R L Beishuizen; Francesca Mangialasche; Mariagnese Barbera; Tiia Ngandu; Nicola Coley; Juliette Guillemont; Stéphanie Savy; Marcel G W Dijkgraaf; Ron J G Peters; Willem A van Gool; Miia Kivipelto; Sandrine Andrieu Journal: BMJ Open Date: 2016-06-10 Impact factor: 2.692